Sophia Wong, Assistant Professor, and Medical Oncologist at the National Cancer Centre Singapore, shared on X:
“IMA203CD8, a co-transduces a CD8αβ co-receptor alongside the PRAME TCR showing impressive ORR 51% in 90 and durability in heavily pre-treated patients of >3L including melanoma, gynaecological, sarcomas. Well tolerated with CRS mostly G1-2.
Many congratulations to Antonia Busse, investigators and Immatics.”
Stay connected to the latest from ESMO 2026 with OncoDaily.
